机构:[1]Department of Radiology, Xuanwu Hospital, Beijing, China放射科首都医科大学宣武医院[2]Department of Emergency, Xuanwu Hospital, Beijing, China急诊科首都医科大学宣武医院[3]Department of Neurology, Xuanwu Hospital, Beijing, China神经内科首都医科大学宣武医院[4]Department of Neurosurgery, Xuanwu Hospital, Beijing, China神经外科首都医科大学宣武医院[5]Biomedical Imaging Research Institute, Cedars Sinai Medical Center, Los Angeles, California[6]Neurology, Beth Israel Deaconess Medical Center, Boston, Massachusetts
Objective The objective of this study was to evaluate the thrombus characteristics affecting the extent of recanalization to identify patients with severe cerebral venous sinus thrombus (CVT) more likely to benefit from endovascular therapy. Methods Severe CVT patients scheduled for endovascular treatment were prospectively recruited into the study. Each thrombosed venous segment was evaluated regarding complete or partial recanalization based on digital subtraction angiography (DSA) after treatment. Magnetic resonance black-blood thrombus imaging (MRBTI) was performed 1 day before endovascular treatment. The signal-to-noise ratio (SNR) of the clot, age of the clot, and baseline volume of the clot were compared between the complete and partial recanalization groups. A logistic regression analysis was performed to identify the association between these clot characteristics and recanalization status. Results Twenty-one CVT patients undergoing endovascular therapy were prospectively included. There were 110 thrombosed segments, 54 of these segments were completely recanalized after endovascular treatment. An acute clot sign (ACS) was found in 39 segments and a subacute clot sign (SCS) was found in 71 segments. There was no significant difference on baseline volume of the clot (1638.8 +/- 1432.2 mm(3) vs. 1957.5 +/- 2056.1 mm(3), P > 0.05) between the complete and partial recanalization groups. Logistic regression analysis showed that ACS on MRBTI was associated with complete recanalization (P < 0.001, odds ratio = 3.937, 95% confidence interval, 1.6-9.5). Interpretation ACS can be used to predict complete recanalization in patients undergoing endovascular treatment. MRBTI provides a robust method to define clot composition and is potentially useful in selecting the most appropriate CVT patients for endovascular treatment.
基金:
Beijing Natural Science Foundation [17L20253]; National Science Foundation of China [91749127, 81830056]; Beijing Municipal Administration of Hospitals Clinical Medicine Development of Special Funding Support [ZYLX201706]
第一作者机构:[1]Department of Radiology, Xuanwu Hospital, Beijing, China
通讯作者:
通讯机构:[*1]Xuanwu Hospital, Capital Medical University, Beijing, China, 100053.
推荐引用方式(GB/T 7714):
Xiaoxu Yang,Fang Wu,Yuehong Liu,et al.Predictors of successful endovascular treatment in severe cerebral venous sinus thrombosis[J].ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY.2019,6(4):755-761.doi:10.1002/acn3.749.
APA:
Xiaoxu Yang,Fang Wu,Yuehong Liu,Jiangang Duan,Ran Meng...&Xunming Ji.(2019).Predictors of successful endovascular treatment in severe cerebral venous sinus thrombosis.ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY,6,(4)
MLA:
Xiaoxu Yang,et al."Predictors of successful endovascular treatment in severe cerebral venous sinus thrombosis".ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY 6..4(2019):755-761